Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001
Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006
Analysis of atherosclerosis in patients with chronic obstructive pulmonary disease by carotid ultrasonography Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Underappreciation of coronary artery disease in patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020
Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
OSA and coronary artery disease Source: Sleep and Breathing Conference 2021 Year: 2021
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010
Clinical and investigational profiles of elevated pulmonary artery pressures in patients with stable chronic obstructive pulmonary diseases Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019
The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005
Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
Impact of a wireless implanted pulmonary artery pressure monitoring system in heart failure patients with comorbid chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
The year in chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical Year in Review Year: 2018
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Role of Rho-kinase pathway in et-1-induced vasoconstriction in pulmonary artery of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009